Charles Schwab Investment Management Inc Aspira Women'S Health Inc. Transaction History

Charles Schwab Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $72,619 - $197,888	-181,549 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$3.19 - $5.48 $17,934 - $30,808	5,622 Added 3.2%	181,549 $591,000
Q2 2021 Aug 16, 2021	SELL	$4.78 - $6.84 $131,459 - $188,113	-27,502 Reduced 13.52%	175,927 $989,000
Q1 2021 May 17, 2021	BUY	$5.9 - $9.13 $69,130 - $106,976	11,717 Added 6.11%	203,429 $1.37 Million
Q4 2020 Feb 16, 2021	SELL	$3.0 - $6.71 $1,470 - $3,287	-490 Reduced 0.25%	191,712 $1.29 Million

Q3 2020 Nov 13, 2020	BUY	$2.54 - $4.56 $230,002 - $412,917	90,552 Added 89.08%	192,202 $593,000
Q2 2020 Aug 14, 2020	BUY	$0.78 - $5.25 $79,287 - $533,662	101,650 New	101,650 $391,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $185M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.